In addition, P7 can also inhibit the promotion effect of FGF2 on the transformation of epithelial ovarian cancer cells from the G0/G1 phase to the S phase and suppress the expression of Cyclin D1 and the activation of the MAPK and AKT signaling pathways, thereby playing a role in the treatment of ovarian cancer [63]. This evidence concerns the gene FGF2 and ovarian carcinoma.